Quest for Growth
Description
Quest for Growth is a prominent publicly listed investment company (BEVEK/SICAF) based in Leuven, Belgium, trading on Euronext Brussels under the ticker QFG. The firm is dedicated to investing in innovative growth companies, primarily focusing on opportunities within Belgium and its neighboring countries. Quest for Growth employs a flexible investment strategy, providing both equity and quasi-equity financing across various stages, from early-stage venture capital to later-stage growth capital, pre-IPO, and even listed companies.
The firm's investment mandate targets sectors characterized by high growth potential and innovation, including life sciences, cleantech, digital technologies, and deep tech. Quest for Growth is known for its active role in supporting the development of promising European companies. While their typical investment range for an initial cheque can vary significantly based on the stage and specific opportunity, they generally participate in rounds with contributions ranging from approximately $535,000 (€0.5 million) to $5,350,000 (€5 million), demonstrating their capacity to support companies from early development through significant growth phases.
As of December 31, 2022, Quest for Growth managed a substantial portfolio with a total fair value of approximately EUR 75.7 million. This diversified portfolio included investments in 27 unlisted companies, reflecting their commitment to private market growth, alongside 17 listed companies, which provides liquidity and exposure to public market performance. This dual approach allows Quest for Growth to balance risk and return across different investment horizons, making them a significant player in the European venture and growth capital landscape.
Investor Profile
Quest for Growth has backed more than 31 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 3% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series D rounds (top funding stages).
- Majority of deals are located in Belgium, The Netherlands, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Typical check size: $535K – $5.3M.
Stage Focus
- Series Unknown (35%)
- Series B (26%)
- Series D (13%)
- Series C (10%)
- Series A (6%)
- Seed (6%)
- Series E (3%)
Country Focus
- Belgium (35%)
- The Netherlands (16%)
- United Kingdom (13%)
- France (13%)
- Germany (10%)
- United States (6%)
- Switzerland (3%)
- Singapore (3%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Software
- Medical
- Manufacturing
- Hardware
- Biopharma
- Information Technology
- Medical Device
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.